文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

衰竭心脏中的线粒体蛋白高度乙酰化

Mitochondrial protein hyperacetylation in the failing heart.

作者信息

Horton Julie L, Martin Ola J, Lai Ling, Riley Nicholas M, Richards Alicia L, Vega Rick B, Leone Teresa C, Pagliarini David J, Muoio Deborah M, Bedi Kenneth C, Margulies Kenneth B, Coon Joshua J, Kelly Daniel P

机构信息

Cardiovascular Metabolism Program, Sanford Burnham Prebys Medical Discovery Institute, Orlando, Florida, USA.

Department of Chemistry, University of Wisconsin - Madison, Madison, Wisconsin, USA; Genome Center of Wisconsin, University of Wisconsin - Madison, Madison, Wisconsin, USA.

出版信息

JCI Insight. 2016 Feb;2(1). doi: 10.1172/jci.insight.84897. Epub 2016 Feb 25.


DOI:10.1172/jci.insight.84897
PMID:26998524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4795836/
Abstract

Myocardial fuel and energy metabolic derangements contribute to the pathogenesis of heart failure. Recent evidence implicates posttranslational mechanisms in the energy metabolic disturbances that contribute to the pathogenesis of heart failure. We hypothesized that accumulation of metabolite intermediates of fuel oxidation pathways drives posttranslational modifications of mitochondrial proteins during the development of heart failure. Myocardial acetylproteomics demonstrated extensive mitochondrial protein lysine hyperacetylation in the early stages of heart failure in well-defined mouse models and the in end-stage failing human heart. To determine the functional impact of increased mitochondrial protein acetylation, we focused on succinate dehydrogenase A (SDHA), a critical component of both the tricarboxylic acid (TCA) cycle and respiratory complex II. An acetyl-mimetic mutation targeting an SDHA lysine residue shown to be hyperacetylated in the failing human heart reduced catalytic function and reduced complex II-driven respiration. These results identify alterations in mitochondrial acetyl-CoA homeostasis as a potential driver of the development of energy metabolic derangements that contribute to heart failure.

摘要

心肌燃料和能量代谢紊乱是心力衰竭发病机制的一部分。最近的证据表明,翻译后机制参与了导致心力衰竭发病的能量代谢紊乱。我们假设,在心力衰竭发展过程中,燃料氧化途径的代谢中间产物积累会驱动线粒体蛋白的翻译后修饰。心肌乙酰化蛋白质组学表明,在明确的小鼠模型心力衰竭早期以及终末期衰竭的人类心脏中,线粒体蛋白赖氨酸广泛发生高乙酰化。为了确定线粒体蛋白乙酰化增加的功能影响,我们聚焦于琥珀酸脱氢酶A(SDHA),它是三羧酸(TCA)循环和呼吸复合体II的关键组成部分。针对在衰竭人类心脏中显示发生高乙酰化的SDHA赖氨酸残基的模拟乙酰化突变降低了催化功能,并减少了复合体II驱动的呼吸作用。这些结果表明,线粒体乙酰辅酶A稳态的改变可能是导致心力衰竭的能量代谢紊乱发展的潜在驱动因素。

相似文献

[1]
Mitochondrial protein hyperacetylation in the failing heart.

JCI Insight. 2016-2

[2]
Tricarboxylic acid cycle activity suppresses acetylation of mitochondrial proteins during early embryonic development in .

J Biol Chem. 2019-1-3

[3]
An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.

Int J Cardiol. 2013-8-6

[4]
Mitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation.

Hum Mol Genet. 2014-7-1

[5]
Role of CoA and acetyl-CoA in regulating cardiac fatty acid and glucose oxidation.

Biochem Soc Trans. 2014-8

[6]
Acetyl-L-carnitine increases mitochondrial protein acetylation in the aged rat heart.

Mech Ageing Dev. 2015-1

[7]
Acute intermittent porphyria causes hepatic mitochondrial energetic failure in a mouse model.

Int J Biochem Cell Biol. 2014-6

[8]
Oxidative post-translational modifications develop LONP1 dysfunction in pressure overload heart failure.

Circ Heart Fail. 2014-4-16

[9]
Proteomic analysis of mitochondria reveals a metabolic switch from fatty acid oxidation to glycolysis in the failing heart.

Sci China C Life Sci. 2009-11

[10]
The mitochondrial lysine acetylome of Arabidopsis.

Mitochondrion. 2014-11

引用本文的文献

[1]
Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets.

Nat Rev Cardiol. 2025-6-22

[2]
Mechano-energetic uncoupling in heart failure.

Nat Rev Cardiol. 2025-6-22

[3]
Mitochondrial medicine: "from bench to bedside" 3PM-guided concept.

EPMA J. 2025-4-15

[4]
Acetyltransferase in cardiovascular disease and aging.

J Cardiovasc Aging. 2024

[5]
Emerging interactions between mitochondria and NAD metabolism in cardiometabolic diseases.

Trends Endocrinol Metab. 2025-2

[6]
Metabolite signaling in the heart.

Nat Cardiovasc Res. 2023-6

[7]
Acetylation of PGK1 at lysine 323 promotes glycolysis, cell proliferation, and metastasis in luminal A breast cancer cells.

BMC Cancer. 2024-8-27

[8]
Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration.

Circulation. 2025-1-7

[9]
NAD+ precursors prolong survival and improve cardiac phenotypes in a mouse model of Friedreich's Ataxia.

JCI Insight. 2024-7-18

[10]
NAD metabolism and heart failure: Mechanisms and therapeutic potentials.

J Mol Cell Cardiol. 2024-10

本文引用的文献

[1]
The Failing Heart Relies on Ketone Bodies as a Fuel.

Circulation. 2016-2-23

[2]
Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure.

Circulation. 2016-2-23

[3]
Lysine Acetylation Activates Mitochondrial Aconitase in the Heart.

Biochemistry. 2015-6-30

[4]
SIRT3 mediates multi-tissue coupling for metabolic fuel switching.

Cell Metab. 2015-4-7

[5]
Site-specific reactivity of nonenzymatic lysine acetylation.

ACS Chem Biol. 2015-1-16

[6]
Novel mouse model of left ventricular pressure overload and infarction causing predictable ventricular remodelling and progression to heart failure.

Clin Exp Pharmacol Physiol. 2015-1

[7]
Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach.

Circ Heart Fail. 2014-11

[8]
The growing landscape of lysine acetylation links metabolism and cell signalling.

Nat Rev Mol Cell Biol. 2014-8

[9]
ROS-triggered phosphorylation of complex II by Fgr kinase regulates cellular adaptation to fuel use.

Cell Metab. 2014-6-3

[10]
Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure.

Genet Mol Res. 2014-1-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索